Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus

Immunology

Volumn 105, Issue 3, 2002, Pages 295-305

  Fraser, Darrilyn G ^a   Oaks, J Lindsay ^a   Brown, Wendy C ^a   McGuire, Travis C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 4; POL PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EQUINE INFECTIOUS ANEMIA VIRUS; GENETIC CONSERVATION; HELPER CELL; HORSE; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RETROVIRUS INFECTION; SEQUENCE HOMOLOGY; TH1 CELL; VIREMIA; VIRUS CAPSID;

ANIMALS; ANTIGENS, VIRAL; CARRIER STATE; CELL DIVISION; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; EQUINE INFECTIOUS ANEMIA; GENE PRODUCTS, GAG; GENE PRODUCTS, POL; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; INTERFERON TYPE II; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; PEPTIDE FRAGMENTS; TH1 CELLS;

EID: 0036223366     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0019-2805.2001.01370.x     Document Type: Article

References (44)

1. Viremia and immunological responses in horses infected with equine infectious anemia virus
2. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids
3. + cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins
4. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process
5. Antigenic drift of equine infectious anemia virus in chronically infected horses
6. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus
7. Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs
8. + T lymphocyte depletion in normal and equine infectious anaemia virus-carrier horses
9. Transmission of equine infectious anemia virus from horses without clinical signs of disease
10. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
11. + lymphocytes
12. + cytotoxic T-cell responses during chronic viral infection
13. Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: Relative stability of CD4 memory under conditions of CD8 memory T cell loss
14. + T cells
15. + T cell responses associated with the control of viremia
16. Cytotoxic T cell responses to DNA vaccination: Dependence on antigen presentation via class II MHC
17. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
18. Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides
19. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans
20. Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus
21. Protocol for the immunodiffusion (Coggins) test for equine infectious anemia
22. Polymorphism of DRA among equids
23. Demonstration of three DRB loci in a domestic horse family
24. Polymorphism and multiple loci for the horse DQA gene
25. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids
26. + T helper lymphocytes from equine infectious anemia virus-infected carrier horses
27. Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses in horses infected with equine herpesvirus 1
28. Quantitation of equine cytokine mRNA expression by reverse transcription-competitive polymerase chain reaction
29. Quantitative characterization of lymphocyte populations in bronchoalveolar lavage fluid and peripheral blood of normal adult Arabian horses
30. Use of monoclonal antibodies and flow cytometry to cluster and analyze leukocyte differentiation molecules
31. Expression of functional protease and subviral particles by vaccinia virus containing equine infectious anaemia virus gag and 5′ pol genes
32. Natural variation of equine infectious anemia virus Gag protein cytotoxic T lymphocyte epitopes
33. Nucleotide sequence analysis of feline immunodeficiency virus: Genome organization and relationship to other lentiviruses
34. + T cells by at least four unrelated HLA-DR molecules
35. Equine infectious anemia virus gag and pol genes: Relatedness to visna and AIDS virus
36. Genotypic and phenotypic characterization of HIV-1 patients with primary infection
37. + cell depletion and progression to AIDS
38. Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis
39. Acute arthritis in caprine arthritis-encephalitis virus challenge exposure of vaccinated or persistently infected goats
40. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus
41. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
42. Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production
43. Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment
44. Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8 (+) T cells and associated with a proliferative response to p24 antigen